FDA approves new drug to treat adults with advanced urothelial or bladder cancer

jeudi 19 décembre 2019

The U.S. Food & Drug Administration granted accelerated approval to the drug enfortumab vedotin (EV) to treat adult patients with advanced urothelial or bladder cancer. FDA approves new drug to treat adults with advanced urothelial or bladder cancer

0 commentaires:

Enregistrer un commentaire